- Activity pressure is positive on the latest completed week.
ALIKO
PAR
Week ended 07 Aug 2026
Weekly Investor Report
Ikonisys S.A. · Healthcare · Medical Devices
Latest close
1.45 EUR
-3.3%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -3.5% below the Trend Line and sits at 18.7% of its 52-week range. The latest completed week returned -3.3%, after a -3.3% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
31
out of 100
Latest Close
1.45 EUR
7 Aug 2026
1W Return
-3.3%
latest completed week
4W Return
-3.3%
short-term follow-through
12W Return
5.1%
quarterly tape
Trend Breadth
36.5%
19 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 36.36% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-3.3%
Latest completed week; four-week move -3.3%.
Indicator stack
20/49
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 36.36%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -3.5% below the Trend Line and sits at 18.7% of its 52-week range. The latest completed week returned -3.3%, after a -3.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3212-week average 0.21
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.32Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -3.3% over four weeks, 5.1% over 12 weeks, and -4.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year19
Trend breadth36.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.15Latest activity-pressure read.
Pressure change-41.9%Four-week change in activity pressure.
Leadership-10.34Latest relative-leadership reading.
RS change-164.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-21.2%Distance below the 52-week high.
13-week volatility3.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher4 of 2614 weeks finished lower.
Best week+12.3%Week of 22 May.
Worst week-4.5%Week of 13 Mar.
Latest week-3.3%Week of 7 Aug.
Shape of recent returns
Strong gains1
Modest gains3
Flat weeks8
Modest losses13
Sharp losses1
Recent vol3.9%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split13/23Count of positive and negative weeks in the 52-week window.
Average skew4.4% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Healthcare
4-week rank51 / 76
Group average0.7%
Trend breadth26.3%
Trend26.3%active weekly trend signals
MD40.8%positive activity pressure
RS19.7%positive relative leadership
Four-week leaders
IndustryFR Medical Devices
4-week rank6 / 13
Group average-5.4%
Trend breadth15.4%
Trend15.4%active weekly trend signals
MD15.4%positive activity pressure
RS15.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape28/100
Trend, activity pressure, participation, and risk combine to a 28/100 tape read.
Indicator analysis36/100Latest 12-week confirmation: trend 0/12, activity pressure 10/12, relative leadership 3/12.
Activity pressure 0.32; No reversal markers Next-Week ExpectancyNegative 36.36%Next-week expectancy is negative with a 36.36% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Ikonisys SA (ALIKO.PA) Stock Price, News & Analyst Forecast Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1.45 EUR | -3.3% | 1.50 EUR | 1.48 EUR | 0.15 | -10.34 | 9.2K | Off |
| 31 Jul 2026 | 1.50 EUR | 0.0% | 1.51 EUR | 1.48 EUR | 0.22 | -5.31 | 0 | Off |
| 24 Jul 2026 | 1.50 EUR | 0.0% | 1.51 EUR | 1.49 EUR | 0.24 | -4.00 | 0 | Off |
| 17 Jul 2026 | 1.50 EUR | 0.0% | 1.52 EUR | 1.49 EUR | 0.25 | -3.77 | 0 | Off |
| 10 Jul 2026 | 1.50 EUR | 0.0% | 1.52 EUR | 1.49 EUR | 0.26 | -3.91 | 0 | Off |
| 3 Jul 2026 | 1.50 EUR | 0.0% | 1.52 EUR | 1.49 EUR | 0.25 | -5.96 | 0 | Off |
| 26 Jun 2026 | 1.50 EUR | 0.0% | 1.53 EUR | 1.49 EUR | 0.28 | -4.78 | 0 | Off |
| 19 Jun 2026 | 1.50 EUR | 0.0% | 1.52 EUR | 1.49 EUR | 0.39 | -5.40 | 0 | Off |
| 12 Jun 2026 | 1.50 EUR | -3.8% | 1.52 EUR | 1.49 EUR | 0.39 | -4.86 | 3.0K | Off |
| 5 Jun 2026 | 1.56 EUR | -2.5% | 1.52 EUR | 1.49 EUR | 0.06 | 0.31 | 3.9K | Off |
| 29 May 2026 | 1.60 EUR | 3.2% | 1.51 EUR | 1.49 EUR | -0.36 | 3.20 | 74.8K | Off |
| 22 May 2026 | 1.55 EUR | 12.3% | 1.51 EUR | 1.49 EUR | -0.88 | 0.72 | 59.8K | Off |
| 15 May 2026 | 1.38 EUR | -1.4% | 1.51 EUR | 1.49 EUR | -1.20 | -8.61 | 63.2K | Off |
| 8 May 2026 | 1.40 EUR | 0.0% | 1.51 EUR | 1.49 EUR | -1.26 | -9.36 | 18.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.